IP Library Patent Application 13004406
Patent Application
App. No. 13/004,406

System, Method and Apparatus for Purifying Biological Fluids Such as Blood and Constituents Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/004,406
Abstract

Provided herein is an innovative hemoperfusion system and method including a thermal-fused broad-spectrum biocidal iodinated interactive polymer for the treatment of biological contaminants in body fluids. In one exemplary embodiment, the system and method utilizes a Triosyn® thermal fused broad-spectrum iodinated interactive polymer, included in a hemoperfusion column, for devitalizing high levels of cell-free microorganisms in whole blood and biological fluids in relation with the characterization of blood cells viability and function post-treatment

Claims (16)

1 . A method for decontaminating blood, comprising:

a) providing a hemoperfusion unit containing a low-density chamber including an effective amount of demand disinfectant, said demand disinfectant being an iodinated resin;

b) separating a unit of blood infected with a quantity of bacteria or viral particles to provide a red blood cell concentrate and a plasma concentrate;

c) discarding the plasma concentrate;

d) diluting the red blood cell concentrate with an aqueous solution;

e) filtering said diluted red blood cell concentrate through said hemoperfusion unit at a selected flow rate,

wherein the amount of bacteria or viral particles is reduced by greater than 90%.)

2 . The method of claim 1 , wherein the amount of bacteria or viral particles is reduced by greater than 95%.)

3 . The method of claim 1 , wherein the amount of bacteria or viral particles is reduced by greater than 99%.)

4 . The method of claim 1 , wherein the bacteria or viral particles are selected from the group consisting of Staphylococcus aureus, E. coli and MS2.)

5 . The method of claim 1 further comprising gravity filtering red blood cell concentrate through a leukocyte filter to remove leukocytes prior to diluting the red blood cell concentrate.)

6 . The method of claim 1 further comprising gravity filtering red blood cell concentrate through a leukocyte filter to remove leukocytes after diluting the red blood cell concentrate.)

7 . The method of claim 1 , wherein the aqueous solution is a saline solution.)

8 . The method of claim 1 , wherein the said flow rate is 50 ml/mm.)

9 . The method of claim 1 , wherein the said flow rate is 20 ml/mm.)

10 . The method of claim 1 , wherein the a low-density chamber further contains hydrodynamic diffusers.

Assignments (4)
SECURITY AGREEMENT Recorded Feb 28, 2013
From: TIOMED INNOVATIONS CORP.
To: FONDACTION, LE FONDS DE DEVELOPPMENT DE LA CONFEDERATION DES SYNDICATES NATIONAUX POUR LA COOPERATION ET L'EMPLOI
Reel/Frame 029900/0962 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2011
From: SAFE LIFE CORP.; SAFE LIFE/TRIOSYN CORP.; TRIOSYN HOLDING, INC.
To: TRIOMED INNOVATIONS CORP.
Reel/Frame 027004/0877 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2011
From: SOFNOV SOCIETE FINANCIERE D'INNOVATION INC.; BUSINESS DEVELOPMENT BANK OF CANADA; SOCIETE INNOVATECH DU GRAND MONTREAL; MACLEOD, RAY; BERGERON, GILES; SL VENTURES; BRB SPORTS UNLIMITED; MARTIN, JACQUES; DONLAN, DAVID A.; O'BRIEN, JOSEPH W.; O'BRIEN, SHIRLEY; HARNELL, WILLIAM; HARNELL, TERESA; CAPOSELLA, CARMINE; JAGOE, HARVEY
To: TRIOSYN CORP.
Reel/Frame 026362/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2011
From: MESSIER, PIERRE J.
To: SAFELIFE/TRIOSYN CORP.
Reel/Frame 026348/0812 →